- Home
- NEWS
- REGIONAL
- THIS WEEK'S PAPER
- BLOGS
- Multimedia
- OPINION
- A&E
- LISTS
- PEOPLE
- EVENTS
- Classifieds
- Subscribe
BioCrossroads
Indianapolis bio sector hopeful as venture firms cash out
April 30, 2011
Chris O'MalleyProfits flowing from earlier investments could mean more available capital, but firms continue to be selective in placing
their bets.
MoreMarcadia Biotech principals ponder next course
March 22, 2011
Chris O'MalleyMarcadia execs French, Hawryluk reflect on massive growth of Carmel firm after sale to Roche.
MoreFranciscan's electronic records rollout shows industry growth
February 23, 2011
J.K. WallFranciscan Alliance will spend more than $100 million over the next two years to install a common electronic medical record
system at its 13 hospitals and more than 165 physician practices. It’s a sign of the growth of the health information
technology industry in Indiana, which a new BioCrossroads report says generates $200 million a year in sales and is growing
at 8 percent annually.
MoreRoche acquires Marcadia Biotech
December 30, 2010
Chris O'MalleyMarcadia Biotech Inc., a Carmel-based biopharmaceutical company founded by prominent scientists from Eli Lilly and Co. in
2006, has been acquired by Swiss life sciences giant Roche.
MoreIndiana Seed Fund makes 11th investment
December 23, 2010
IBJ StaffA $250,000 investment in Aarden Pharmaceuticals will go toward advancing tuberculosis therapy through the pre-clinical development
stage.
MoreLilly Endowment gives $35M to start pharmacy school
December 20, 2010
J.K. WallManchester College will use money to launch the state's third program offering doctorates in pharmacy.
MoreState adds record number of life sciences jobs
December 11, 2010
IBJ StaffTwenty companies committed this year to add more than 4,000 jobs.
MoreIndiana life sciences upstarts tap health reform booty
November 6, 2010
IBJ StaffThe federal legislation is roundly criticized at a BioCrossroads meeting, but some firms have found a silver lining.
MoreIndiana's life sciences industry sees trouble ahead
October 30, 2010
Associated PressIndiana's life sciences industry has weathered the recession relatively well, but Eli Lilly's struggles and tight capital
markets could threaten the future.
MoreBioCrossroads helping laid-off life sciences workers land safely
October 30, 2010
Chris O'MalleyIndiana firms have dismissed more than 1,400 life science workers over the last two years. Now BioCrossroads has launched
a website that aims to keep that talent in the state.
MoreIndiana life sciences sector copes with shrinking VC pool
October 30, 2010
Chris O\'malleyVenture funds nationwide crested at $100 billion in 2000, but that number last year had drooped to $18 billion.
MoreEndocyte's $86M IPO plan a boon for Indiana, investors
August 28, 2010
Greg AndrewsVenture capitalists in Indiana and nationally have thrown money at the company with abandon. Local investors include CID Capital,
Clarian Health Ventures and the Indiana Future Fund.
MoreIndiana Seed Fund nearing end of $6 million stash
June 5, 2010
Chris O'MalleyHaving invested in 10 companies since 2005 and with its $6 million pot of money running low, the Indiana Seed Fund is nearing
a crossroads.
MoreOrthoWorx initiative names executive director
June 3, 2010
IBJ StaffNot-for-profit launched last year by BioCrossroads and Indiana's orthopedic companies names Zimmer Inc. executive Brad Bishop
to lead the initiative.
MoreIndianapolis startup attacks Alzheimer's disease
May 29, 2010
Norm HeikensAgeneBio Inc. this month landed a $300,000 investment from the Indiana Seed Fund to fund operations, bolster its intellectual
property, and begin learning how to make a drug into a once-a-day pill.
MoreIndiana's growth in life sciences jobs beats national average
May 8, 2010
IBJ StaffBloomington led the nation as the No. 1 small city in medical devices and equipment.
MoreChao exit hurts drug development industry
April 28, 2010
J.K. WallPurdue University’s decision to close the Chao Center in West Lafayette is a setback for Indiana’s effort to grow
a vibrant contract drug manufacturing sector. But it’s just the latest in a series of unexpected changes—not all
for
the worse—since Indianapolis-based BioCrossroads launched a contract drug manufacturing initiative in late 2007.
MoreIndiana companies that serve pharmaceutical industry grew in 2009
February 20, 2010
IBJ StaffThe firms continued to grow over the last year but face increasing challenges, according to a new report by Indianapolis-based
life sciences trade group BioCrossroads.
MoreReport: State's pharmaceutical contractors continue to grow
February 10, 2010
A report set to be released Wednesday by local life sciences industry group BioCrossroads says Indiana companies providing
contract pharmaceutical research and manufacturing services are weathering the economic downturn and are growing.
MoreEntrepreneur says quality of venture capital as important as quantity
January 2, 2010
IBJ StaffJim Pearson knows a thing or two about raising money from venture capitalists. And he has some advice for BioCrossroads:
Teach entrepreneurs the value of money.
MoreFirst Indiana Future Fund off to a slow start
December 19, 2009
Peter SchnitzlerMore than half of the venture capital fund's original investors took a pass on its $58 million successor, the newly launched
INext.
MoreNew BioCrossroads venture fund raises $58 million
December 16, 2009
Peter SchnitzlerThe new INext fund is the successor to the $73 million Indiana Future Fund, which the life science initiative raised in 2003.
MoreCompany's medical device earns expedited review
December 9, 2009
FAST Diagnostics LLC said initial human trials on its method to measure kidney function faster and more accurately than existing
techniques could begin as early as next year, with commercialization following by 2012.
MoreDowntown life sciences corridor flagged for development
November 28, 2009
IBJ StaffA new task force is charged with making recommendations for development of the city’s downtown certified technology
park.
MoreAarden Pharmaceuticals chose Indianapolis over San Diego for headquarters
November 14, 2009
IBJ StaffThanks partly to a state grant and support from Indiana’s BioCrossroads life sciences initiative, principals “decided
locating here would give Aarden a better chance of success.
More
Sponsored by
ADVERTISEMENT
on Facebook & Twitter
on Facebook & Twitter
 Follow IBJ's Tweets on these topics: |
||
| @IBJNews | @Propertylines | @IBJTheScore |
| @IBJArts | @IBJHealthcare | @IBJDining |
| @IBJLists | @IBJSmallbiz | |
ADVERTISEMENT
Back to TopCopyright © All Rights Reserved. Privacy Policy | Terms of Use.
Design, CMS, Hosting & Web Development :: ePublishing.
Additional Hosting & Delivery by
RKW's comments read like a modern "Chicken Little". As a Raintree resident for many years, "Yes, I'm ready for this." Matter of fact, I welcome The Farm because it's a development that compliments our town, brings new and desirable shopping & dining closer (specialty grocer, upscale shops, micro brew pub, etc), offers upscale condos for empty nesters who want to stay in Zionsville, is being planned and constructed by local, well-reputed firms and, of course, provides desirable non property tax benefits. We all knew the Pittman's were going to develop their property sooner than later. That one of the Pittman's will continue to live on the property helps assure The Farm will be everything promised. This also sets a standard for other developers as to the quality of future developments - which should keep an ugly Walmart at bay for decades. As we've no meglomaniac mayor, I seriously doubt Zionsville would ever aspire to over-priced statues or subsidized retail rents. And we already have a very nice public theater, the Zionsville Performing Arts Center, that meets our cultural needs quite nicely.
Do we add (or subtract) these from the bounty we recieve from RTWFL, Daylight Savings Time, corporate tax giveaways, and the crack job IEDC is doing?? Or is Mike going to blame these on Mitch?
Who makes Tater Tots? They would be a good sponsor, because $3 Million for the alleged "Greatest Spectacle In Racing" is taters. Tiny, tiny taters. But at least they are making up something of the losses accumulated over the years in this dying sport. Buttock in seat is certainly not doing it, nor eyeball on TV, as evidenced by the lack of both.
We loved lakehouse and think the Arbor Village would be a great location. It is less than 2 miles from over 1000 rooftops in the 225,000 to over 1 million range. Many people could use the great fishers trail system to bike or walk there. Just an idea Scotty -- but maybe something closer to 3 Wiseman would good. The only microbrew in area is Ram (boring)
True, it's an ESPN production, but ESPN is just another name for ABC Sports, or what used to be ABC Sports since ABC Sports no longer exists as a name. ESPN=ABC Sports= ESPN. ESPN is, according to Forbes "the world's most valuable media property" worth $40 billion. Despite that, they fired 400 people this week.